Clinical Trials Browser

Neuroblastoma, Ganglioneuroblastoma

Brain Neoplasms

Urinary Bladder Neoplasms

Urothelial Carcinoma of the Bladder

Urinary Bladder Neoplasms

Urinary Bladder Neoplasms

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Carcinoma, Laryngeal Neoplasms, Mouth Neoplasms

Non-Muscle Invasive Bladder Urothelial Carcinoma

Urinary Bladder Neoplasms

Brain Neoplasms, Craniopharyngioma

Glioblastoma

Astrocytoma, Glioblastoma, Glioma, Lymphoma, Follicular, Oligodendroglioma

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Urinary Bladder Neoplasms

Glioblastoma

Alzheimer Disease, Sarcoma, Giant Cell Tumor of Bone

Muscle-invasive Urothelial Cancer of the Bladder

Squamous Cell Carcinoma of Head and Neck

Estrogen Receptor Positive Breast Cancer

Urinary Bladder Neoplasms

Urinary Bladder Neoplasms, Neoplasms

Astrocytoma, Ependymoma, Glioblastoma

Urinary Bladder Neoplasms, Prostatic Hyperplasia

Glioblastoma, Glioma

Urinary Bladder Neoplasms

Glioblastoma

Glioblastoma

Pathologic Complete Response, Neoplasms, Sarcoma

Urinary Bladder Neoplasms

Urinary Bladder Neoplasms

Brain Neoplasms, Glioma

Urinary Bladder Neoplasms

Pancreatic Neoplasms

Pancreatic Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Paranasal Sinus Neoplasms

Clinical Trials

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain Tumors

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN)

Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE Trial

Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer

Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer

A Randomized Trial of Bicalutamide in Non-Muscle Invasive Bladder Cancer

Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer

Lifileucel With Reduced Dose Fludarabine/Cyclophosphamide Lymphodepletion and Interleukin-2 for the Treatment of Patients With Unresectable or Metastatic Melanoma

A Phase II Trial of Intensity-Modulated Proton Therapy for Incompletely Resected Craniopharyngioma and Observation for Craniopharyngioma After Radical Resection

DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)

DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma

Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas

GAIN-BCG

Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer

Niraparib/TTFields in GBM

PROMIS and Mobility Evaluation in Sarcoma Patients

Pembrolizumab (MK3475), Gemcitabine, and Concurrent Hypofractionated Radiation Therapy for Muscle-Invasive Urothelial Cancer of the Bladder

FID-007 Followed by Standard of Care Surgery in Head and Neck Cancer

Tn-Miner

NEO-BLAST

TEMPO-MIBC

Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine

OUTCOMES of SIMULTANEOUS TRANSURETHRAL PROSTATE and BLADDER TUMOR RESECTION VERSUS TRANSURETHRAL BLADDER TUMOR RESECTION in BLADDER TUMOR with BLADDER PROSTATE HYPERPLASIA

Glioma Microenvironment an Exploratory Study

Cryoablation Versus BCG Instillation Therapy for High-risk NMIBC

RESBIOP

PALSUR

SarQuantIRM

CBPTMI

Validation of VI-RADS for the Detection of Detrusor Muscle Invasion

Cetuximab-IRDye 800CW in Detecting Tumors in Patients With Malignant Glioma Undergoing Surgery

Quantitative Imaging Biomarkers for Sarcoma

Observation Versus Immediate Surgery of Low Risk Bladder Cancer

NEOPA

Chemoradiation in Locally Advanced Pancreatic Cancer

Celecoxib in Treating Patients With Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer

Chemoradiotherapy Followed by Surgery for Advanced Paranasal Sinus Cancer